These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36343537)

  • 41. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Forced degradation study of racecadotril: Effect of co-solvent, characterization of degradation products by UHPLC-Q-TOF-MS/MS, NMR and cytotoxicity assay.
    Chiguru V; Lingesh A; R S; N S
    J Pharm Biomed Anal; 2016 Sep; 128():9-17. PubMed ID: 27209450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat.
    Mahajan R; Kumar S; Parupalli R; Khemchandani R; Kanchupalli V; Nanduri S; Samanthula G; Asthana A
    J Pharm Biomed Anal; 2023 Sep; 234():115517. PubMed ID: 37320975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
    Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
    J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
    Kathar N; Rajput N; Jadav T; Sengupta P
    J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Separation, identification and characterization of stress degradation products of bortezomib using HPLC and LC-MS.
    Purushotham Reddy C; Ramakrishna K; Narayana Rao K
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):115-125. PubMed ID: 33827302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions.
    Baira SM; Kalariya PD; Nimbalkar R; Garg P; Srinivas R; Talluri MVNK
    Rapid Commun Mass Spectrom; 2018 Feb; 32(3):212-220. PubMed ID: 29134712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive study to identify and characterize major degradation products of Ivermectin drug substance including its degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 May; 214():114730. PubMed ID: 35334396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and validation of a stability-indicating high performance liquid chromatographic assay for determination of cariprazine in bulk form and in drug product.
    Toujani E; Mejri W; Lassoued HE; Toujani S; Fliss O; Cheikh MHB; Safta F
    Ann Pharm Fr; 2023 Jan; 81(1):83-93. PubMed ID: 36037933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of Ocular Toxicity of Potential Degradation Products of Proparacaine Hydrochloride Subjected under ICH Recommended Stress Conditions.
    Mahajan A; Coelho A; Pissurlenkar R; Fernandes A; Tagalpallewar A
    J Chromatogr Sci; 2023 Apr; 61(4):393-401. PubMed ID: 35543315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
    Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
    J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LC-MS/MS studies of ritonavir and its forced degradation products.
    Rao RN; Ramachandra B; Vali RM; Raju SS
    J Pharm Biomed Anal; 2010 Dec; 53(4):833-42. PubMed ID: 20619992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of degradation products of indacaterol using liquid chromatography/mass spectrometry.
    Yerra NV; Dadinaboyina SB; Vigjna Abbaraju L; Kumar Talluri M; Reddy Thota J
    Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):425-431. PubMed ID: 33153322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural identification of degradants of moexipril by LC-MS/MS.
    Challa PR; K R; K M V NR
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LC and LC-MS/MS studies for the identification and characterization of degradation products of acebutolol.
    Rakibe U; Tiwari R; Mahajan A; Rane V; Wakte P
    J Pharm Anal; 2018 Dec; 8(6):357-365. PubMed ID: 30595941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.